The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Abstract
Dendrimers are routinely synthesized as tuneable nanostructures that may be designed and regulated as a function of their size, shape, surface chemistry and interior void space. They are obtained with structural control approaching that of traditional biomacromolecules such as DNA/RNA or proteins and are distinguished by their precise nanoscale scaffolding and nanocontainer properties. As such, these important properties are expected to play an important role in the emerging field of nanomedicine. This review will describe progress on the use of these features for both targeted diagnostic imaging and drug-delivery applications. Recent efforts have focused on the synthesis and pre-clinical evaluation of a multipurpose STARBURST® PAMAM (polyamidoamine) dendrimer prototype that exhibits properties suitable for use as: (i) targeted, diagnostic MRI (magnetic resonance imaging)/NIR (near-IR) contrast agents, (ii) and/or for controlled delivery of cancer therapies. Special emphasis will be placed on the lead candidate, namely [core: 1,4-diaminobutane; G (generation)=4.5], [dendri-PAMAM(CO2Na)64]. This dendritic nanostructure (i.e. ∼5.0 nm diameter) was selected on the basis of a very favourable biocompatibility profile [The Nanotechnology Characterization Laboratory (NCL), an affiliate of the National Cancer Institute (NCI), has completed extensive in vitro studies on the lead compound and have found it to be very benign, non-immunogenic and highly biocompatible], the expectation that it will exhibit desirable mammalian kidney excretion properties and demonstrated targeting features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Self-citationDesigning dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Self-citationLundquist, J. J., & Toone, E. J. (2002) · Chemical Reviews · doi:10.1021/cr000418f · Cited by 1,576
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Self-citationDendrimers and Other Dendritic Polymers
(2001) · Wiley eBooks · doi:10.1002/0470845821 · Cited by 1,429
Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
Self-citationKukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Discovery of dendrimers and dendritic polymers: A brief historical perspective*
Tomalia, D. A., & Fréchet, J. M. J. (2002) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.10301 · Cited by 908
Self-citationDendrimers and other dendritic polymers
Fréchet, J. M. J., & Tomalia, D. A. (2001) · Cited by 873
Self-citationDendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
Wiener, E., Brechbiel, M. W., Brothers, H., Magin, R. L., Gansow, O. A., Tomalia, D. A., & Lauterbur, P. C. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310102 · Cited by 718
Self-citationKojima, C., Kono, K., Maruyama, K., & Takagishi, T. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000583 · Cited by 663
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Starburst dendrimers. 5. Molecular shape control
Naylor, A. M., Goddard, W. A., Kiefer, G. E., & Tomalia, D. A. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00188a079 · Cited by 513
Self-citationDendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
(2005) · CRC Press eBooks · doi:10.1201/9781420027921 · Cited by 381
Handbook of nanoscience, engineering, and technology
(2003) · Materials Today · doi:10.1016/s1369-7021(03)00431-0 · Cited by 319
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., & Holan, G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050023q · Cited by 314
Syntheses and some applications of chemically defined multivalent glycoconjugates
Roy, R. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80037-6 · Cited by 296
D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269
Tomalia, D. A., Berry, V., Hall, M., & Hedstrand, D. M. (1987) · Macromolecules · doi:10.1021/ma00171a051 · Cited by 215
Self-citationTargeting Dendrimer-Chelates to Tumors and Tumor Cells Expressing the High-Affinity Folate Receptor
WIENER, E. C., KONDA, S., SHADRON, A., BRECHBIEL, M., & GANSOW, O. (1997) · INVESTIGATIVE RADIOLOGY · doi:10.1097/00004424-199712000-00005 · Cited by 214
Design of Dendritic Macromolecules Containing Folate or Methotrexate Residues
Kono, K., Liu, M., & Fréchet, J. M. J. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990082k · Cited by 207
Dendrimer-based Macromolecular MRI Contrast Agents: Characteristics and Application
Kobayashi, H., & Brechbiel, M. W. (2003) · Molecular Imaging · doi:10.1162/15353500200303100 · Cited by 202
In Vitro Targeting of Synthesized Antibody-Conjugated Dendrimer Nanoparticles
Thomas, T. P., Patri, A. K., Myc, A., Myaing, M. T., Ye, J. Y., Norris, T. B., & Baker, J. R. (2004) · Biomacromolecules · doi:10.1021/bm049704h · Cited by 193
Zanini, D., & Roy, R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963874n · Cited by 182
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T. S., Tjarks, W., Barth, R. F., Claffey, K., & Backer, J. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0161 · Cited by 180
Tomalia, D. A., Huang, B., SWANSON, D. R., Brothers, H. M., & Klimash, J. W. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00430-7 · Cited by 171
Self-citationJiang, Y.-H., Emau, P., Cairns, J. S., Flanary, L., Morton, W. R., McCarthy, T. D., & Tsai, C.-C. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.207 · Cited by 160
Handbook of Nanoscience, Engineering, and Technology
Goddard, W. A., III, Brenner, D. W., Lyshevski, S. E., & IAFRATE, G. J. (2002) · CRC Press eBooks · doi:10.1201/9781420040623 · Cited by 155
Röckendorf, N., & Lindhorst, T. K. (2001) · Topics in current chemistry · doi:10.1007/3-540-45003-3_6 · Cited by 117
The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
Baker, J. R., Quintana, A., Piehler, L. T., Banazak-Holl, M., Tomalia, D. A., & Raczka, E. (2001) · Biomedical Microdevices · doi:10.1023/a:1011485622697 · Cited by 107
Self-citationTomalia, D. A., Brothers, H. M., Piehler, L. T., Durst, H. D., & Swanson, D. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062684999 · Cited by 103
Self-citationSynthesis and characterization of branched poly(l-glutamic acid) as a biodegradable drug carrier
Tansey, W., Shi, K., Cao, X., Melancon, M. P., Wallace, S., & Li, C. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.005 · Cited by 101
Introduction to “Dendrimers and Dendritic Polymers”
Tomalia, D. A., & Fréchet, J. M. J. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.03.003 · Cited by 80
Self-citationPeptide and glycopeptide dendrimers. Part II
Vepřek, P., & Ježek, J. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199905)5:5<203::aid-psc181>3.0.co;2-n · Cited by 62
Studies on PEGylated and Drug-Loaded PAMAM Dendrimers
Pan, G., Lemmouchi, Y., Akala, E. O., & Bakare, O. (2004) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505049656 · Cited by 60
Cited by
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Multimodality Imaging Probes: Design and Challenges
Louie, A. (2010) · Chemical Reviews · doi:10.1021/cr9003538 · Cited by 1,044
Metadata
- Authors
- Tomalia, D. A., Reyna, L. A., & Svenson, S.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-01-22
- Volume
- 35
- Issue
- 1
- Pages
- 61-67
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2060279237
- Cited by
- 496
- References
- 40
- FWCI
- 41.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.